Results 71 to 80 of about 1,417,901 (252)

A cost utility and cost effectiveness analysis of different oral antiviral medications in patients with HBeAg-Negative chronic hepatitis B in Iran: an economic microsimulation decision model [PDF]

open access: yes, 2016
Background: Although hepatitis B infection is the major cause of chronic liver disease in Iran, no studies have employed economic evaluations of the medications used to treat Iranian patients with chronic hepatitis B (CHB).
Alavian, Seyed Moayed   +9 more
core   +1 more source

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARD), targeted synthetic DMARD (tsDMARD) and biosimilar DMARD (bsDMARD) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity [PDF]

open access: green, 2023
Juthamas Prawjaeng   +7 more
openalex   +1 more source

On the Choice of Metrics in Dynamic Welfare Analysis: Utility versus Money Measures [PDF]

open access: yes
This paper is concerned with the choice of metrics for social cost-benefit analysis and dynamic welfare comparisons. In a utility-theoretic framework, we show that there is always a money measure that can serve as a substitute for the maximized utility ...
Li, Chuan-Zhong, Löfgren, Karl-Gustaf
core   +1 more source

Three‐year cost utility analysis of mini versus standard slings: A trial based economic evaluation

open access: yesBJUI Compass
Objective To report on the cost‐effectiveness of adjustable anchored single‐incision mini‐slings (mini‐slings) compared with tension‐free standard mid‐urethral slings (standard slings) in the surgical management of female stress urinary incontinence (SUI)
Mary Kilonzo   +8 more
doaj   +1 more source

PCN199 COST-UTILITY ANALYSIS OF THE BI-, QUADRI-, AND NONA-VALENT HPV-VACCINE: A DECISION ANALYTIC MODEL [PDF]

open access: bronze, 2019
N.K. Hermansen   +3 more
openalex   +1 more source

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany [PDF]

open access: gold, 2022
Daniel Molnar   +11 more
openalex   +1 more source

COST-EFFECTIVENESS AND COST-UTILITY OF GENOTHERAPEUTIC DRUG NEOVASCULGEN IN TREATMENT OF CHRONIC LOWER LIMB ISCHEMIA

open access: yesМедицинский совет, 2017
Pl-VEGF165 (Neovasculgen) is a new genotherapeutic drug for treatment of chronic lower limb ischemia.  It is registered in Russia and underwent effectiveness assessment in clinical trial.
S. L. Plavinsky, P. I. Shabalkin
doaj   +1 more source

Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system

open access: yesAlexandria Journal of Medicine, 2014
Due to the significant boost in community expenditure with health topics, mainly regarding drugs, numerous countries, have already put into operation, or are in the process of arguing the adoption of actions to guarantee the excellence of health care ...
Adanela Musaraj   +2 more
doaj   +1 more source

Cost projections for Redox Energy storage systems [PDF]

open access: yes
A preliminary design and system cost analysis was performed for the redox energy storage system. A conceptual design and cost estimate was prepared for each of two energy applications: (1) electric utility 100-MWh requirement (10-MW for ten hours) for ...
Hall, G., Michaels, K.
core   +1 more source

Home - About - Disclaimer - Privacy